UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

A genomic pathway approach to a complex disease: axon guidance and Parkinson disease

PLoS genetics, 2007-06, Vol.3 (6), p.e98-e98

2007

Volltextzugriff (PDF)

Lrrk2 and Lewy body disease

Annals of neurology, 2006-02, Vol.59 (2), p.388-393

2006

Volltextzugriff (PDF)

Preventing Paclitaxel-Induced Peripheral Neuropathy: A Phase II Trial of Vitamin E Supplementation

Journal of pain and symptom management, 2006-09, Vol.32 (3), p.237-244

2006

Volltextzugriff (PDF)

A randomized controlled trial evaluating the efficacy and safety of vitamin E supplementation for protection against cisplatin-induced peripheral neuropathy: final results

Supportive care in cancer, 2006-11, Vol.14 (11), p.1134-1140

2006

Volltextzugriff (PDF)

CX-8998, a potent, selective T-type calcium channel antagonist dose-dependently suppresses seizures in the WAG/Rij genetic model of absence epilepsy. (P5.281)

Neurology, 2018-04, Vol.90 (15_supplement)

2018

Volltextzugriff (PDF)

A questionnaire-based (UM-PDHQ) study of hallucinations in Parkinson's disease

BMC neurology, 2008-06, Vol.8 (1), p.21-21, Article 21

2008

Volltextzugriff (PDF)

A comparison of jaw-closing and jaw-opening idiopathic oromandibular dystonia

Parkinsonism & related disorders, 2006-03, Vol.12 (2), p.115-118

2006

Volltextzugriff (PDF)

Beyond Parkinson disease: amyotrophic lateral sclerosis and the axon guidance pathway

PloS one, 2008-01, Vol.3 (1), p.e1449-e1449

2008

Volltextzugriff (PDF)

Optimizing human post-mortem brain tissue gene expression profiling in Parkinson's disease and other neurodegenerative disorders: From target "fishing" to translational breakthroughs

Journal of neuroscience research, 2007-11, Vol.85 (14), p.3013-3024

2007

Volltextzugriff (PDF)

Multi-modal hallucinations and cognitive function in Parkinson's disease

Dementia and geriatric cognitive disorders, 2010-01, Vol.30 (1), p.51-56

2010

Volltextzugriff (PDF)

Management of the extrapyramidal syndrome in chronic acquired hepatocerebral degeneration (CAHD)

Movement disorders, 2005-08, Vol.20 (8), p.1088-1089

2005

Volltextzugriff (PDF)

Cardiac denervation and dysautonomia in Parkinson's disease: A review of screening techniques

Parkinsonism & related disorders, 2008-11, Vol.14 (7), p.524-531

2008

Volltextzugriff (PDF)

Eating dysfunction associated with oromandibular dystonia: clinical characteristics and treatment considerations

Head & face medicine, 2006-12, Vol.2 (1), p.47-47, Article 47

2006

Volltextzugriff (PDF)

A Proof-of-Principle Quantitative EEG Study of an Oral, Potent and Selective T-Type Calcium Modulator in Healthy Volunteers (P4.261)

Neurology, 2018-04, Vol.90 (15_supplement)

2018

Volltextzugriff (PDF)

Is there a role for naturally occurring cyanobacterial toxins in neurodegeneration? The beta-N-methylamino-L-alanine (BMAA) paradigm

Neurochemistry international, 2007-06, Vol.50 (7-8), p.998-1003

Papapetropoulos, Spiridon

2007

Volltextzugriff (PDF)

Natural History of Progressive Supranuclear Palsy: A Clinicopathologic Study from a Population of Brain Donors

European neurology, 2005-01, Vol.54 (1), p.1-9

2005

Volltextzugriff (PDF)

A Phase 2 Efficacy Study of an Oral, Potent and Selective T-Type Calcium (Cav3) Modulator in Essential Tremor Patients (T-CALM): Design and Dose Selection Rationale (P6.060)

Neurology, 2018-04, Vol.90 (15_supplement)

2018

Volltextzugriff (PDF)

Machine learning algorithms applied to digital biomarker data (iMotor) discriminate Parkinson’s motor status (P3.042)

Neurology, 2018-04, Vol.90 (15_supplement)

2018

Volltextzugriff (PDF)

A Phase 2a Study of CX-8998, an Oral, Potent and Selective T-Type Calcium Modulator in Adolescents and Young Adults with Absence Epilepsy: Rationale for population and dose selection (P5.282)

Neurology, 2018-04, Vol.90 (15_supplement)

2018

Volltextzugriff (PDF)

Cause, seasonality of death and co-morbidities in progressive supranuclear palsy (PSP)

Parkinsonism & related disorders, 2005-11, Vol.11 (7), p.459-463

2005

Volltextzugriff (PDF)

Peripheral nerve damage associated with administration of taxanes in patients with cancer

Critical reviews in oncology/hematology, 2008-06, Vol.66 (3), p.218-228

2008

Volltextzugriff (PDF)

Reversal of allodynia and neurophysiological outcomes by CX-8998, a potent, selective T-type calcium channel modulator, in a model of bortezomib induced peripheral neurotoxicity (S7.004)

Neurology, 2018, Vol.90 (15_supplement)

2018

Volltextzugriff (PDF)

Case of Pediatric Acquired Chronic Hepatocerebral Degeneration

Pediatric neurology, 2008, Vol.38 (1), p.67-70

2008

Volltextzugriff (PDF)

Is there a role for naturally occurring cyanobacterial toxins in neurodegeneration? The beta -N-methylamino -L-alanine (BMAA) paradigm: Mechanisms of neurodegeneration

Neurochemistry international, 2007, Vol.50 (7-8), p.998-1003

PAPAPETROPOULOS, Spiridon

2007

Volltextzugriff (PDF)

Is there a role for naturally occurring cyanobacterial toxins in neurodegeneration?

Neurochemistry international, 2007, Vol.50 (7), p.998-1003

Papapetropoulos, Spiridon

2007

Volltextzugriff (PDF)

1 – 25 von 117

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(106)
Mit Volltextzugriff
(103)

Publikationsform

Sprache

Englisch
(117)

Erscheinungsjahr

n.n

Thema

Humans
(86)
Science & Technology
(82)
Life Sciences & Biomedicine
(81)
Neurosciences & Neurology
(72)
Clinical Neurology
(68)
Female
(59)
Male
(52)
Aged
(43)
Middle Aged
(39)
Neurology
(39)
Biological And Medical Sciences
(32)
Medical Sciences
(30)
Parkinson's Disease
(22)
Adult
(19)
Aged, 80 And Over
(17)
Neurosciences
(16)
Parkinson Disease - Genetics
(13)
Parkinson Disease - Physiopathology
(11)
Treatment Outcome
(11)
Brain - Pathology
(10)

15 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

A genomic pathway approach to a complex disease: axon guidance and Parkinson disease

Lrrk2 and Lewy body disease

Preventing Paclitaxel-Induced Peripheral Neuropathy: A Phase II Trial of Vitamin E Supplementation

A randomized controlled trial evaluating the efficacy and safety of vitamin E supplementation for protection against cisplatin-induced peripheral neuropathy: final results

CX-8998, a potent, selective T-type calcium channel antagonist dose-dependently suppresses seizures in the WAG/Rij genetic model of absence epilepsy. (P5.281)

A questionnaire-based (UM-PDHQ) study of hallucinations in Parkinson's disease

A comparison of jaw-closing and jaw-opening idiopathic oromandibular dystonia

Beyond Parkinson disease: amyotrophic lateral sclerosis and the axon guidance pathway

Optimizing human post-mortem brain tissue gene expression profiling in Parkinson's disease and other neurodegenerative disorders: From target "fishing" to translational breakthroughs

Multi-modal hallucinations and cognitive function in Parkinson's disease

Management of the extrapyramidal syndrome in chronic acquired hepatocerebral degeneration (CAHD)

Cardiac denervation and dysautonomia in Parkinson's disease: A review of screening techniques

Eating dysfunction associated with oromandibular dystonia: clinical characteristics and treatment considerations

A Proof-of-Principle Quantitative EEG Study of an Oral, Potent and Selective T-Type Calcium Modulator in Healthy Volunteers (P4.261)

Is there a role for naturally occurring cyanobacterial toxins in neurodegeneration? The beta-N-methylamino-L-alanine (BMAA) paradigm

Natural History of Progressive Supranuclear Palsy: A Clinicopathologic Study from a Population of Brain Donors

A Phase 2 Efficacy Study of an Oral, Potent and Selective T-Type Calcium (Cav3) Modulator in Essential Tremor Patients (T-CALM): Design and Dose Selection Rationale (P6.060)

Machine learning algorithms applied to digital biomarker data (iMotor) discriminate Parkinson’s motor status (P3.042)

A Phase 2a Study of CX-8998, an Oral, Potent and Selective T-Type Calcium Modulator in Adolescents and Young Adults with Absence Epilepsy: Rationale for population and dose selection (P5.282)

Cause, seasonality of death and co-morbidities in progressive supranuclear palsy (PSP)

Peripheral nerve damage associated with administration of taxanes in patients with cancer

Reversal of allodynia and neurophysiological outcomes by CX-8998, a potent, selective T-type calcium channel modulator, in a model of bortezomib induced peripheral neurotoxicity (S7.004)

Case of Pediatric Acquired Chronic Hepatocerebral Degeneration

Is there a role for naturally occurring cyanobacterial toxins in neurodegeneration? The beta -N-methylamino -L-alanine (BMAA) paradigm: Mechanisms of neurodegeneration

Is there a role for naturally occurring cyanobacterial toxins in neurodegeneration?

Suchergebnisse filtern